All Posts:cancer
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
(September 14, 2020) — Julie Shanholtz was having an uneventful summer in 2017 working full time with the same employer she’d had for the past 30 years when she developed an “odd cough” that quickly became severe, but no other symptoms. “I had always been very active and healthy — and didn’t smoke,” the 54-year-old […]
Category: Lombardi Stories
-
Georgetown Lombardi Patient Records Song with Cancer Can Rock
(August 14, 2020) — As an amateur musician, songwriting has been an outlet for decades for Seth Lucash, a patient of Michael B. Atkins, MD, deputy director at Georgetown Lombardi Comprehensive Cancer Center. “When I was about 16, I just started sitting at the piano and writing,” he said. “Writing was a very big release […]
Category: Lombardi Stories
-
First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight
(July 31, 2020) — In the field of breast screening, 3D imaging, or tomosynthesis mammography, has become the go-to screening modality over conventional digital mammography in recent years. But does 3D screening actually improve detection of — and survival from — life-threatening breast cancers, or does conventional mammography perform just as well at a lower […]
Category: Lombardi Stories
-
Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer
WASHINGTON (April 29, 2020) — Georgetown Lombardi Comprehensive Cancer Center, in collaboration with MedStar Georgetown University Hospital, has begun a study to test for specific virus antibodies in people with cancer, who are vulnerable to COVID-19. The FDA, has approved (under an emergency use authorization) only a few tests produced commercially to detect antibodies against […]
Category: News Release
-
Adding Smoking Cessation to Lung Cancer Screening Can Reduce Mortality by 14%
WASHINGTON (March 9, 2020) — Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study led by researchers at the University of Michigan and Georgetown Lombardi Comprehensive Cancer Center. The study is published […]
Category: News Release
-
Georgetown Breast Cancer Researcher Inducted as AAAS Fellow
(February 15, 2020) — For a career aimed at decoding the biggest challenge in treating the most common cancer in women, the Council of the American Association for the Advancement of Science (AAAS) inducted Georgetown’s Robert Clarke, PhD, DSc, as an AAAS Fellow. The Council elects Fellows annually to honor scientists whose “efforts on behalf […]
Category: Lombardi Stories
-
Cancer Organization Recommends Genetic Testing for Jewish People of Ashkenazi Descent
(January 28, 2020) — New guidelines from a leading cancer organization have broadened criteria for hereditary cancer genetic testing. The change means more people who could be at increased risk of developing cancer should consider being tested. The guidelines, released in December 2019 by the National Comprehensive Cancer Network, now indicate that all adult Ashkenazi […]
Category: Lombardi Stories
-
Gut Bacteria May Be One Culprit for Increase of Colorectal Cancer in Younger People
SAN FRANCISCO (January 21, 2020) — A bacteria typically linked to periodontal disease, Fusobacterium nucleatum (F. nuc), could play an important role in the rising incidence of colorectal cancer in people under the age of 45. Another type of bacteria, Moraxella osloensis, has been found in colorectal cancer tumors at a nearly four-fold higher rate […]
Category: News Release
-
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]
Category: News Release
-
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
WASHINGTON (December 30, 2019) — Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast […]
Category: News Release